Bioreactive Innovations

Rodrigo is a founding member of the Bioreactive Innovations, Inc., an emerging biopharmaceutical company pioneering innovative approaches to the discovery and development of next generation antimicrobials.

Bioreactive Innovation’s technology pipeline includes next generation antimicrobials, drug reactivity enhancers, beta lactamase inhibitors and antimicrobial surface coatings.

BIA 303 – Promising best-in-class antibiotic

BIA 343 – Promising best-in-class antibiotic

BIX 505 – Antimicrobial coating compound (features Surfaces Platform Technology)

BIX-729 – β-lactamase inhibitor  (features affinity drug delivery technology)

Discovery Phase Chart2

Their Product Development Pipeline has the potential to lead in the areas of infectious diseases, oncology, virology and biodefense.

He currently serves as an advisor.

Comments are closed.